DOD’s Drug Price Controls Unfair, D.C. Circuit Hears

A government contractor trade group urged the D.C. Circuit to reverse a ruling upholding the U.S. Department of Defense’s authority to impose involuntary price controls on drugmakers for drugs covered under the military’s Tricare health care program that beneficiaries purchase from retail pharmacies.
Law360